title: In vivo properties of oncostatin M.
authors.affiliation: Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121, USA.
authors.forename: P M
authors.initials: PM
authors.lastname: Wallace
authors.forename: J F
authors.initials: JF
authors.lastname: Macmaster
authors.forename: J R
authors.initials: JR
authors.lastname: Rillema
authors.forename: K A
authors.initials: KA
authors.lastname: Rouleau
authors.forename: M B
authors.initials: MB
authors.lastname: Hanson
authors.forename: S A
authors.initials: SA
authors.lastname: Burstein
authors.forename: M
authors.initials: M
authors.lastname: Shoyab
mesh_terms: D000209:Acute-Phase Proteins / Q000096:biosynthesis; D000818:Animals; D016207:Cytokines / Q000493:pharmacokinetics / Q000494:pharmacology*; D006410:Hematopoiesis / Q000187:drug effects; D015850:Interleukin-6 / Q000096:biosynthesis / Q000494:pharmacology; D008657:Metabolic Clearance Rate; D051379:Mice; D053683:Oncostatin M; D010455:Peptides / Q000493:pharmacokinetics / Q000494:pharmacology*; D010976:Platelet Count; D011994:Recombinant Proteins; D000685:Serum Amyloid A Protein / Q000096:biosynthesis; D013921:Thrombocytopenia / Q000188:drug therapy; D014018:Tissue Distribution
chemical_list: D000209:Acute-Phase Proteins; D016207:Cytokines; D015850:Interleukin-6; C508352:Osm protein, mouse; D010455:Peptides; D011994:Recombinant Proteins; D000685:Serum Amyloid A Protein; D053683:Oncostatin M